Inmolecule Nanotech, S.A.
MLINA | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- ES0105908000
- LEI:
- 959800F0D3TQYVTXW034
- Country:
- Spain
- Address:
- N/A
- Website:
- https://www.inmolecule.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Inmolecule Nanotech, S.A. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Inmolecule Nanotech, S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inmolecule Nanotech, S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing genetic medicines for severe CNS and neurodegenerative disorders.
United States of America
PASG
United States of America
PASG
A med-tech firm offering diagnostics for esophageal precancer & digital health for cancer care.
United States of America
PAVM
United States of America
PAVM
Biotech using an EDO platform to treat genetic neuromuscular & neurological diseases.
United States of America
PEPG
United States of America
PEPG
Develops antibody drugs for cancer, provides research support, and sells diagnostic reagents.
Japan
4882
Japan
4882
Sweden
PEXA B
AI-powered drug development for rare and refractory diseases, focusing on oncology.
South Korea
388870
South Korea
388870
Develops precision phage therapy to treat resistant bacterial infections.
France
ALPHE
France
ALPHE
CRO providing humanized liver mouse models and testing services for preclinical drug development.
Japan
6190
Japan
6190
Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.
Sweden
PILA
Sweden
PILA
Offers smart, soil-free hydroponic systems and data services for homes and urban farms.
United States of America
PFAI
United States of America
PFAI